PAM
FULC icon

Panagora Asset Management’s Fulcrum Therapeutics FULC Stock Holding History

Panagora Asset Management’s Portfolio FULC Stock Details FULC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.87M Buy
+243,565
New +$2.26M 0.01% 599
2024
Q4 		– Sell
-97,891
Closed -$349K – 1181
2024
Q3 		$349K Buy
+97,891
New +$726K ﹤0.01% 1009
2023
Q2 		– Sell
-22,299
Closed -$63.6K – 1335
2023
Q1 		$63.6K Sell
22,299
-937
-4% -$8.39K ﹤0.01% 1424
2022
Q4 		$169K Sell
23,236
-5,825
-20% -$38K ﹤0.01% 1386
2022
Q3 		$235K Buy
29,061
+415
+1% +$2.97K ﹤0.01% 1338
2022
Q2 		$140K Hold
28,646
– – ﹤0.01% 1426
2022
Q1 		$677K Buy
28,646
+106
+0.4% +$1.5K ﹤0.01% 1104
2021
Q4 		$505K Buy
28,540
+133
+0.5% +$2.63K ﹤0.01% 1211
2021
Q3 		$801K Buy
28,407
+27,579
+3,331% +$523K ﹤0.01% 1069
2021
Q2 		$9K Buy
828
+436
+111% +$4.41K ﹤0.01% 2295
2021
Q1 		$5K Hold
392
– – ﹤0.01% 2575
2020
Q4 		$5K Buy
+392
New +$4.43K ﹤0.01% 2458

Other funds holding FULC

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
FTM
First Turn Management Del Mar, California $895M AUM 261.28% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

Panagora Asset Management's FULC Position: Q1 2026 in Review

Panagora Asset Management opened a new position in Fulcrum Therapeutics (FULC) in Q1 2026: 243,565 shares worth $1.87M. The stake represents 0.01% of the portfolio and ranks #599 among its holdings. This is a return to the name: Panagora Asset Management previously reported a position in FULC as recently as Q3 2024.

Panagora Asset Management first reported a position in FULC in Q4 2020 and has held it in 12 quarters since. 169 funds tracked by Wall St. Rank hold FULC as of Q1 2026.

  • Panagora Asset Management held 243,565 shares of Fulcrum Therapeutics worth $1.87M as of Q1 2026.
  • Fulcrum Therapeutics was a new Panagora Asset Management position in Q1 2026.
  • Fulcrum Therapeutics made up 0.01% of Panagora Asset Management's portfolio in Q1 2026, its #599 holding.
  • Panagora Asset Management first reported a position in Fulcrum Therapeutics in Q4 2020 and has held it in 12 quarters since.
  • 169 funds tracked by Wall St. Rank held Fulcrum Therapeutics as of Q1 2026.

Based on Panagora Asset Management's 13F filing for Q1 2026, filed 14 May 2026.